Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Telios Pharma Inc.
Sponsor

Telios Pharma Inc.

United States 275 Shoreline Drive Suite 325, 94065-1407, United States

About the sponsor

Telios Pharma Inc. supports clinical research in B-cell malignancies, with attention to chronic lymphocytic leukemia and small lymphocytic lymphoma. The funded studies also include treatment settings for relapsed/refractory disease and treatment-naïve patient groups.

  • Chronic lymphocytic leukemia
  • Small lymphocytic lymphoma
  • Relapsed/refractory B-cell disease

These trials reflect a therapeutic focus on hematologic cancers where symptom control and disease response remain key clinical priorities.

About Specializations

Telios Pharma Inc. runs clinical trials in conditions such as Indolent systemic mastocytosis, Chronic lymphocytic leukaemia, B-cell small lymphocytic lymphoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Indolent systemic mastocytosis

Recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:1-4-{[6-Amino-5-(4-Phenoxy-Phenyl)-Pyrimidin-4-Ylamino]-Methyl}-4-Fluoro-Piperidin-1-Yl)-Propenone
  • Sponsor:Telios Pharma Inc.

Chronic lymphocytic leukaemia+1

Not recruiting
InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:1-4-{[6-Amino-5-(4-Phenoxy-Phenyl)-Pyrimidin-4-Ylamino]-Methyl}-4-Fluoro-Piperidin-1-Yl)-Propenone
  • Sponsor:Telios Pharma Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.